Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.
Schooler NR, Buchanan RW, Laughren T, Leucht S, Nasrallah HA, Potkin SG, Abi-Saab D, Berardo CG, Bugarski-Kirola D, Blaettler T, Edgar CJ, Nordstroem AL, O'Gorman C, Garibaldi G.
Schooler NR, et al. Among authors: garibaldi g.
Schizophr Res. 2015 Mar;162(1-3):169-74. doi: 10.1016/j.schres.2014.12.001. Epub 2015 Jan 9.
Schizophr Res. 2015.
PMID: 25579053
Review.